We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
The Writers’ e-Publishing Community, with leading-edge technology, LinkedIn for writers, on-line destination for contemporary writing. In 2015 “CUT” will become the world’s largest e-book publisher by author numbers. Over 700 pro-writers already pre-registered. CUT sells e-books, readable on ALL e-readers. Writers create content, driving traffic, reducing costs. e-Book publication is free. CUT receives 99 year rights and a  50/50 revenue share. CUT are building huge content, with over 170 e-books published already.
days to go: Expired investment: £95,656
In 2015 “CUT” aims to become the world’s largest e-book publisher by author numbers. Over 700 pro-writers pre-registered before CUT even went live. CUT is a writers’ e-publishing community, powered by leading-edge technology. Imagine a LinkedIn for writers that is also an on-line destination for contemporary writing. CUT sells e-books, readable on ALL e-readers. Writers create content for CUT and this content drives traffic to the site. Leading edge publishing technology minimises costs so that e-Book publication carries no charge to writers. In turn, CUT receives 99 year rights on a 50/50 revenue share. CUT building huge content, over 300 e-books published already.
days to go: Expired investment: £106,306
Reducing the cost of orthopaedic equipment by using compression screws and titanium maxiangle locking plates. DC Surgical Supplies have acquired an exclusive license with Palmer & Baker with the aim of helping the NHS cut the cost of purchasing regular-use equipment by as much as 35%. Their product is CE Certified and has been featured in The Telegraph.
days to go: Expired investment: £99,000
EMIXIT has built a B2B ecommerce platform wholesaling products from UK suppliers directly to trade buyers across Europe. Over 40 brands with 250+ products have already registered on the platform paying a fee. EMIXIT allows buyers to make up mixed pallets from different suppliers, in their local language, over labelled and delivered to the door – a “one-stop-shop”. Their service is aimed at buyers from small retail or foodservice chains to large multiple supermarkets and hotel/restaurant chains. www.emixit.eu.
days to go: Expired investment: £58,320
Erpingham House is the UK’s largest vegan restaurant whose aim is to make plant-based dining into the mainstream and provide delicious, healthy food and drinks to people. The company has earned nationwide recognition and, it has been listed in The Times top 20 vegetarian restaurants. It has also been featured in The Guardian and on channel 4’s “what Britain bought.” EH has served over 12,000 customers in its first year and, it has risen to over 20,000 followers on Instagram. The funds will be used to expand the brand & open a second site in Brighton.
days to go: Expired investment: £192,280
Fuudel seamlessly connects food operators to consumers using an on demand service. Their platform goes beyond ordering, providing cutting edge tools and services to help food businesses to thrive. Founder Dabier Miya previously had a highly successful enterprise software sales career and in 2004 began what was intended to be a one off investment in a restaurant venture which then led to a decade journey and half a dozen restaurants. 
days to go: Expired investment: £70,675
An innovation event that displays the greatest in medical healthcare technologies within exhibitions, conferences and workshops. GIANT Health has over 2000 delegates registered, with 235 speakers and 33 exhibitors whilst being sponsored by 8 global companies. Current revenue streams consist of event ticket sales, partnership packages, stage demos, etc. Events are held across Europe, with international expansion in the next phase.
days to go: Expired investment: £62,770
Gigride is a one-stop-shop for musicians, DJs, venues, promoters, to come together and produce gigs. The company is bringing the live music industry into the 21st century. It is the only platform known to enlist attendance of bands’ past shows. Gigride is initially focusing on capturing the bookings market before perfecting a longer-term business model. The company's objective is to enable organisers to make informed booking decisions and support revenues by maximising attendance. Gigride also aims at bringing the UK’s estimated 500k bands, 30k promoters, and 130k music venues, together in one online marketplace. 
days to go: Expired investment: £59,640
Halfspace is a company that leverages advanced audience data management technology and analytics to offer comprehensive digital marketing and technology solutions to clients operating in the sports, entertainment, media, and gaming sectors. They are a data-driven marketing and technology group focused on serving the needs of the sports and entertainment industries.
days to go: Expired investment: £1,500,000
Inspira Pharmaceuticals (IP) is forming a possible new therapy for COVID-19. IP asserts that its in-lab plant-based molecular formulation has killed over 95% of the SARS-CoV-2 virus. The company aims to understand whether a COVID-19 patient can safely inhale the formulation directly into their lungs as an effective treatment. IP has secured cornerstone investment from biotech angel investors and a Singaporean Venture Capitalist (VC) for its formula. IP argues that its technology has the potential for addressing other respiratory infections such as cystic fibrosis, influenza and the common cold in the coming months. The company will use the investment to develop an effective new drug, which will include further laboratory analysis, safety testing, and preparation for human trials.
days to go: Expired investment: £357,179
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph